121 related articles for article (PubMed ID: 11106108)
1. Mitoxantrone-related acute myelocytic leukemias.
Hossfeld DK
Ann Oncol; 2000 Oct; 11(10):1215-6. PubMed ID: 11106108
[No Abstract] [Full Text] [Related]
2. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
Au WY; Chan LC; Liang R; Kwong YL
Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
[No Abstract] [Full Text] [Related]
3. Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer.
Melillo LM; Sajeva MR; Musto P; Perla G; Cascavilla N; Minervini MM; D'Arena G; Carotenuto M
Leukemia; 1997 Dec; 11(12):2211-3. PubMed ID: 9447844
[No Abstract] [Full Text] [Related]
4. Acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis.
Mogenet I; Simiand-Erdociain E; Canonge JM; Pris J
Ann Pharmacother; 2003 May; 37(5):747-8. PubMed ID: 12708958
[No Abstract] [Full Text] [Related]
5. Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone.
Heesen C; Bruegmann M; Gbdamosi J; Koch E; Mönch A; Buhmann C
Mult Scler; 2003 Mar; 9(2):213-4. PubMed ID: 12708818
[No Abstract] [Full Text] [Related]
6. Therapy-related leukemia in mitozantrone treated patients.
Goodkin DE
Mult Scler; 2003 Aug; 9(4):426. PubMed ID: 12926850
[No Abstract] [Full Text] [Related]
7. Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
Jaster JH; Niell HB; Dohan FC; Smith TW
Neurology; 2003 Apr; 60(8):1399-400; author reply 1400. PubMed ID: 12707461
[No Abstract] [Full Text] [Related]
8. Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the prostate: a case report and brief review.
Bowles DW; Flaig TW
Cancer Invest; 2006; 24(5):517-20. PubMed ID: 16939961
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
Ellis R; Boggild M
Mult Scler; 2009 Apr; 15(4):505-8. PubMed ID: 19251838
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer.
Martinez V; Mir O; Dômont J; Bouscary D; Goldwasser F
Anticancer Drugs; 2007 Feb; 18(2):233-5. PubMed ID: 17159610
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
12. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
Pascual AM; Téllez N; Boscá I; Mallada J; Belenguer A; Abellán I; Sempere AP; Fernández P; Magraner MJ; Coret F; Sanz MA; Montalbán X; Casanova B
Mult Scler; 2009 Nov; 15(11):1303-10. PubMed ID: 19825889
[TBL] [Abstract][Full Text] [Related]
13. Tracking chemotherapy's effects on secondary cancers.
Brower V
J Natl Cancer Inst; 2013 Oct; 105(19):1421-2. PubMed ID: 24052617
[No Abstract] [Full Text] [Related]
14. Therapy-related acute myelogenous leukemia and myelodysplastic syndrome.
Borthakur G; Estey AE
Curr Oncol Rep; 2007 Sep; 9(5):373-7. PubMed ID: 17706165
[TBL] [Abstract][Full Text] [Related]
15. [Therapy-related acute myeloid leukemia: role of DNA repair].
Guièze R; Ravinet A; Hermet E; Maliki Y; de Botton S; Bay JO
Bull Cancer; 2011 Mar; 98(3):247-55. PubMed ID: 21427028
[TBL] [Abstract][Full Text] [Related]
16. Oesophageal post-therapy myeloid sarcoma masquerading as poorly differentiated adenocarcinoma: a diagnostic pitfall.
Karamchandani DM; Go P; Bayerl M; Karamchandani K
Histopathology; 2022 Feb; 80(3):604-606. PubMed ID: 34355418
[No Abstract] [Full Text] [Related]
17. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Kitazawa J; Ito E; Arai K; Yokoyama M; Fukayama M; Imashuku S
Med Pediatr Oncol; 2001 Aug; 37(2):153-4. PubMed ID: 11496359
[No Abstract] [Full Text] [Related]
18. Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
Colovic N; Suvajdzic N; Kraguljac Kurtovic N; Djordjevic V; Dencic Fekete M; Drulovic J; Vidovic A; Tomin D
Biomed Pharmacother; 2012 Apr; 66(3):173-4. PubMed ID: 22440894
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
Brassat D; Recher C; Waubant E; Le Page E; Rigal-Huguet F; Laurent G; Edan G; Clanet M
Neurology; 2002 Sep; 59(6):954-5. PubMed ID: 12297591
[TBL] [Abstract][Full Text] [Related]
20. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis.
Sumrall A; Dreiling B
J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
